Skip to content
Neat Digest

Providing Stem Cells During Pregnancy to Infants with Neural Tube Defect Enhances Quality of Life, Trial Finds

An innovative clinical study has revealed that delivering regenerative cells to unborn babies affected by spina bifida during corrective surgery may represent a "important advancement" in managing prenatal disorders.

Trial Details and Safety

The research conducted in the United States focused on six unborn babies with the 'open' form of spina bifida. Medical teams placed mother's placental stem cells to the surface of the baby's spinal cord as part of the surgical correction.

Significantly, the cell therapy proved to be secure. The study team reported that the therapy did not induce cancerous growths, hinder surgical recovery, or block the correction of co-occurring hindbrain herniation.

Positive Developments

Post-birth MRI scans indicated a complete reversal of brainstem displacement in every participant. This favorable anatomical change is strongly associated with enhanced physical outcomes.

"In the event it allows more children capable of walking who otherwise would not, it could establish itself as the conventional approach," commented the principal investigator. "These findings are extremely promising and create a pathway toward numerous possible innovative interventions."

Broader Impact and Encouragement

Experts not involved in the trial have suggested that additional validation of these apparent benefits could signal a "fresh chapter" in prenatal intervention. The potential to improve neural deficits seen in utero is regarded as a paradigm-shifting aim.

Particularly welcome would be better management of continence and digestive health, which are common challenges for people affected by this disorder.

Looking Ahead

Despite this being a first-in-human effort focused on a handful of cases, its safety demonstration and positive signals offer a robust platform for expanded clinical research. The integration of stem cell therapy with current in-utero repair procedures holds considerable promise for improving the prognosis for infants diagnosed prenatally with this neural tube defect.

About the author

Melanie Sullivan

Maya Chen is a tech journalist and digital strategist with over a decade of experience covering emerging technologies and startup ecosystems.

Neat Digest

Type to search articles.